The function of mitochondrial CYP1A1 in the lipid metabolism.
| Project/Area Number |
21590319
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
General medical chemistry
|
|---|
| Research Institution | Nihon University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 生体分子医学 / チトクロームP450 / ミトコンドリア / 生体異物代謝 / 脂質代謝 |
|---|
| Research Abstract |
To understand the physiological functions of polycyclic aromatic hydrocarbons(PHAs) induced microsomal versus mitochondrial CYP1A1, it is the microsomal rather than mitochondrial CYP1A1 enzyme that protects against oral BaP toxicity. Because of metabolic delay of PHAs causes abnormal expression of transporter genes, PHAs is induced abnormal lipid metabolism. Our data support the likelihood that it is the microsomal rather than mitochondrial CYP1A1 enzyme that protects against PHAs induced mitochondrial dysfunction.
|
Report
(4 results)
Research Products
(4 results)
